Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adverum Biotechnologies

2.96
+0.23008.42%
Post-market: 2.960.00000.00%17:59 EDT
Volume:594.67K
Turnover:1.76M
Market Cap:61.84M
PE:-0.45
High:3.02
Open:2.78
Low:2.74
Close:2.73
Loading ...
Apr 15, 2025

Major Issues Report

Form 8-K - Current report
Apr 15, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 19, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]